These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 17642233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S, Ferraccioli G, Ferri C, Galeazzi M, Lapadula G, Cerinic MM, Montecucco C, Triolo G, Trotta F, Valentini G.
    Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.
    Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, Baumgartner SW.
    J Rheumatol; 2011 Jul; 38(7):1273-81. PubMed ID: 21572150
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
    Segal B, Rhodus NL, Patel K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [Abstract] [Full Text] [Related]

  • 11. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F, Murdaca G, Ghio M, Indiveri F.
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [Abstract] [Full Text] [Related]

  • 12. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.
    Baker DE.
    Rev Gastroenterol Disord; 2004 Nov; 4(4):196-210. PubMed ID: 15580154
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW.
    Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
    [Abstract] [Full Text] [Related]

  • 14. [Meta analysis of infection risks of anti-TNF-α treatment in rheumatoid arthritis].
    Xie X, Chen J, Peng Y, Gao J, Tian J, Ling G, Du J, Mao N, Wu P, Li F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):722-36. PubMed ID: 23908082
    [Abstract] [Full Text] [Related]

  • 15. Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure.
    Bennett AN, Peterson P, Zain A, Grumley J, Panayi G, Kirkham B.
    Rheumatology (Oxford); 2005 Aug; 44(8):1026-31. PubMed ID: 15870150
    [Abstract] [Full Text] [Related]

  • 16. Safety of biologic therapies--an update.
    Keystone EC.
    J Rheumatol Suppl; 2005 Mar; 74():8-12. PubMed ID: 15742458
    [Abstract] [Full Text] [Related]

  • 17. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y.
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [Abstract] [Full Text] [Related]

  • 18. A new era in rheumatoid arthritis treatment.
    Costello JC, Halverson PB.
    WMJ; 2003 Apr; 102(7):29-33. PubMed ID: 14711021
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
    Bombardieri S, Ruiz AA, Fardellone P, Geusens P, McKenna F, Unnebrink K, Oezer U, Kary S, Kupper H, Burmester GR, Research in Active Rheumatoid Arthritis (ReAct) Study Group.
    Rheumatology (Oxford); 2007 Jul; 46(7):1191-9. PubMed ID: 17504821
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ, van de Putte LB, Breedveld FC.
    Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.